Effect of ursodeoxycholic acid and endoscopic sphincterotomy in long-term stenting for common bile duct stones

Toshihiro Nishizawa, Hidekazu Suzuki, Masahiko Takahashi, Hiroshi Kaneko, Masayuki Suzuki, Toshifumi Hibi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background and Aim: We investigated the patency rate of a biliary stent and the effects of ursodeoxycholic acid (UDCA) therapy and endoscopic sphincterotomy (EST) for difficult-to-remove common bile duct stones. Method: A total of 63 endoscopic retrograde cholangiopancreatographies (ERCPs) were performed in 36 patients (mean age, 86.0 years; male-female, 17:19) for stenting. Among the 63 subjects, 28 were further treated with EST; 20, with UDCA therapy; and 43, without UDCA therapy. Results: The mean patency time was significantly longer in the UDCA treatment group (1,012 days) than in the "stent without UDCA" group (354 days; P=0.0002; hazard ratio, 0.253). The mean patency time was significantly longer in the patients who had stent placement with EST (1074 days) than in those who had stent placement without EST (279 days; P=0.001; hazard ratio, 0.439). The mean patency time was significantly longer in the patients who had stent placement with UDCA therapy and EST (1211 days) than in the patients who had stent placement with either UDCA therapy or EST (425 days; P=0.031; hazard ratio, 0.3292). The mean patency time was significantly longer in the patients who had stent placement with either UDCA therapy or EST than in those who had stent placement without UDCA therapy or EST (263 days; P=0.0465; hazard ratio, 0.5124). Conclusion: Biliary stenting combined with UDCA therapy and EST may be considered as an effective treatment method for cases of common bile duct stones in elderly patients that are difficult to remove.

Original languageEnglish
Pages (from-to)63-67
Number of pages5
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume28
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Endoscopic Sphincterotomy
Ursodeoxycholic Acid
Common Bile Duct
Stents
Therapeutics
Endoscopic Retrograde Cholangiopancreatography

Keywords

  • Biliary stent
  • Common bile duct (CBD) stones
  • Endoscopic sphincterotomy
  • Ursodeoxycholic acid

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Effect of ursodeoxycholic acid and endoscopic sphincterotomy in long-term stenting for common bile duct stones. / Nishizawa, Toshihiro; Suzuki, Hidekazu; Takahashi, Masahiko; Kaneko, Hiroshi; Suzuki, Masayuki; Hibi, Toshifumi.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 28, No. 1, 2013, p. 63-67.

Research output: Contribution to journalArticle

Nishizawa, Toshihiro ; Suzuki, Hidekazu ; Takahashi, Masahiko ; Kaneko, Hiroshi ; Suzuki, Masayuki ; Hibi, Toshifumi. / Effect of ursodeoxycholic acid and endoscopic sphincterotomy in long-term stenting for common bile duct stones. In: Journal of Gastroenterology and Hepatology (Australia). 2013 ; Vol. 28, No. 1. pp. 63-67.
@article{9e70dfda69604469a389f015ea8a289a,
title = "Effect of ursodeoxycholic acid and endoscopic sphincterotomy in long-term stenting for common bile duct stones",
abstract = "Background and Aim: We investigated the patency rate of a biliary stent and the effects of ursodeoxycholic acid (UDCA) therapy and endoscopic sphincterotomy (EST) for difficult-to-remove common bile duct stones. Method: A total of 63 endoscopic retrograde cholangiopancreatographies (ERCPs) were performed in 36 patients (mean age, 86.0 years; male-female, 17:19) for stenting. Among the 63 subjects, 28 were further treated with EST; 20, with UDCA therapy; and 43, without UDCA therapy. Results: The mean patency time was significantly longer in the UDCA treatment group (1,012 days) than in the {"}stent without UDCA{"} group (354 days; P=0.0002; hazard ratio, 0.253). The mean patency time was significantly longer in the patients who had stent placement with EST (1074 days) than in those who had stent placement without EST (279 days; P=0.001; hazard ratio, 0.439). The mean patency time was significantly longer in the patients who had stent placement with UDCA therapy and EST (1211 days) than in the patients who had stent placement with either UDCA therapy or EST (425 days; P=0.031; hazard ratio, 0.3292). The mean patency time was significantly longer in the patients who had stent placement with either UDCA therapy or EST than in those who had stent placement without UDCA therapy or EST (263 days; P=0.0465; hazard ratio, 0.5124). Conclusion: Biliary stenting combined with UDCA therapy and EST may be considered as an effective treatment method for cases of common bile duct stones in elderly patients that are difficult to remove.",
keywords = "Biliary stent, Common bile duct (CBD) stones, Endoscopic sphincterotomy, Ursodeoxycholic acid",
author = "Toshihiro Nishizawa and Hidekazu Suzuki and Masahiko Takahashi and Hiroshi Kaneko and Masayuki Suzuki and Toshifumi Hibi",
year = "2013",
doi = "10.1111/jgh.12012",
language = "English",
volume = "28",
pages = "63--67",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Effect of ursodeoxycholic acid and endoscopic sphincterotomy in long-term stenting for common bile duct stones

AU - Nishizawa, Toshihiro

AU - Suzuki, Hidekazu

AU - Takahashi, Masahiko

AU - Kaneko, Hiroshi

AU - Suzuki, Masayuki

AU - Hibi, Toshifumi

PY - 2013

Y1 - 2013

N2 - Background and Aim: We investigated the patency rate of a biliary stent and the effects of ursodeoxycholic acid (UDCA) therapy and endoscopic sphincterotomy (EST) for difficult-to-remove common bile duct stones. Method: A total of 63 endoscopic retrograde cholangiopancreatographies (ERCPs) were performed in 36 patients (mean age, 86.0 years; male-female, 17:19) for stenting. Among the 63 subjects, 28 were further treated with EST; 20, with UDCA therapy; and 43, without UDCA therapy. Results: The mean patency time was significantly longer in the UDCA treatment group (1,012 days) than in the "stent without UDCA" group (354 days; P=0.0002; hazard ratio, 0.253). The mean patency time was significantly longer in the patients who had stent placement with EST (1074 days) than in those who had stent placement without EST (279 days; P=0.001; hazard ratio, 0.439). The mean patency time was significantly longer in the patients who had stent placement with UDCA therapy and EST (1211 days) than in the patients who had stent placement with either UDCA therapy or EST (425 days; P=0.031; hazard ratio, 0.3292). The mean patency time was significantly longer in the patients who had stent placement with either UDCA therapy or EST than in those who had stent placement without UDCA therapy or EST (263 days; P=0.0465; hazard ratio, 0.5124). Conclusion: Biliary stenting combined with UDCA therapy and EST may be considered as an effective treatment method for cases of common bile duct stones in elderly patients that are difficult to remove.

AB - Background and Aim: We investigated the patency rate of a biliary stent and the effects of ursodeoxycholic acid (UDCA) therapy and endoscopic sphincterotomy (EST) for difficult-to-remove common bile duct stones. Method: A total of 63 endoscopic retrograde cholangiopancreatographies (ERCPs) were performed in 36 patients (mean age, 86.0 years; male-female, 17:19) for stenting. Among the 63 subjects, 28 were further treated with EST; 20, with UDCA therapy; and 43, without UDCA therapy. Results: The mean patency time was significantly longer in the UDCA treatment group (1,012 days) than in the "stent without UDCA" group (354 days; P=0.0002; hazard ratio, 0.253). The mean patency time was significantly longer in the patients who had stent placement with EST (1074 days) than in those who had stent placement without EST (279 days; P=0.001; hazard ratio, 0.439). The mean patency time was significantly longer in the patients who had stent placement with UDCA therapy and EST (1211 days) than in the patients who had stent placement with either UDCA therapy or EST (425 days; P=0.031; hazard ratio, 0.3292). The mean patency time was significantly longer in the patients who had stent placement with either UDCA therapy or EST than in those who had stent placement without UDCA therapy or EST (263 days; P=0.0465; hazard ratio, 0.5124). Conclusion: Biliary stenting combined with UDCA therapy and EST may be considered as an effective treatment method for cases of common bile duct stones in elderly patients that are difficult to remove.

KW - Biliary stent

KW - Common bile duct (CBD) stones

KW - Endoscopic sphincterotomy

KW - Ursodeoxycholic acid

UR - http://www.scopus.com/inward/record.url?scp=84871641726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871641726&partnerID=8YFLogxK

U2 - 10.1111/jgh.12012

DO - 10.1111/jgh.12012

M3 - Article

VL - 28

SP - 63

EP - 67

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 1

ER -